2 domains / 4 areas / 3 specializations
Federal Joint Committee (G-BA)
Data updated
Germany’s highest joint self-governing HTA decision body for coverage and evidence appraisal, including esketamine/Spravato dossiers.
Reimbursement & Market Access Snapshot
Health EconomistsService Model
Public Payer / National Coverage Authority
Jurisdiction
National
Coverage
1 country
Last Verified
Apr 8, 2026
Focus Areas
Evidence Requirements
Market Access Notes
G-BA publishes formal benefit-assessment resolutions that directly shape German reimbursement access; esketamine has an AMNOG evaluation and English resolution materials.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Active
Public Sector Governance Snapshot
Health Technology Assessment AgenciesAuthority Type
Health Technology Assessment Agency
Jurisdiction
National
Coverage
1 country
Framework Status
Active
Function Areas
Governance Notes
Wave 5 L3 completion pass for Federal Joint Committee (G-BA).
Verification
Verified
Psychedelic Engagement
Psychedelic-Adjacent Focus
Last Verified
Apr 16, 2026
Verification Notes
Official HTA decision body with direct esketamine (Spravato) appraisal materials.
Policy Instruments
Quick Facts
- Website
- Visit